349 related articles for article (PubMed ID: 26405107)
41. GM1 ganglioside-independent intoxication by Cholera toxin.
Cervin J; Wands AM; Casselbrant A; Wu H; Krishnamurthy S; Cvjetkovic A; Estelius J; Dedic B; Sethi A; Wallom KL; Riise R; Bäckström M; Wallenius V; Platt FM; Lebens M; Teneberg S; Fändriks L; Kohler JJ; Yrlid U
PLoS Pathog; 2018 Feb; 14(2):e1006862. PubMed ID: 29432456
[TBL] [Abstract][Full Text] [Related]
42. Association of cholera toxin with Vibrio cholerae outer membrane vesicles which are internalized by human intestinal epithelial cells.
Chatterjee D; Chaudhuri K
FEBS Lett; 2011 May; 585(9):1357-62. PubMed ID: 21510946
[TBL] [Abstract][Full Text] [Related]
43. Interaction of pyrene-labeled monosialoganglioside GM1 micelles with cholera toxin.
Picking WD
Biochem Biophys Res Commun; 1993 Sep; 195(3):1153-8. PubMed ID: 8216243
[TBL] [Abstract][Full Text] [Related]
44. Cholera: pathophysiology and emerging therapeutic targets.
Muanprasat C; Chatsudthipong V
Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
[TBL] [Abstract][Full Text] [Related]
45. Binding of cholera toxin B subunit to intestinal epithelial cells.
Navolotskaya EV; Sadovnikov VB; Lipkin VM; Zav'yalov VP
Toxicol In Vitro; 2018 Mar; 47():269-273. PubMed ID: 29262310
[TBL] [Abstract][Full Text] [Related]
46. Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus.
Liljeqvist S; Samuelson P; Hansson M; Nguyen TN; Binz H; Ståhl S
Appl Environ Microbiol; 1997 Jul; 63(7):2481-8. PubMed ID: 9212399
[TBL] [Abstract][Full Text] [Related]
47. Cautionary note on the use of the B subunit of cholera toxin as a ganglioside GM1 probe: detection of cholera toxin A subunit in B subunit preparations by a sensitive adenylate cyclase assay.
Spiegel S
J Cell Biochem; 1990 Mar; 42(3):143-52. PubMed ID: 2156874
[TBL] [Abstract][Full Text] [Related]
48. Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants.
Merritt EA; Sarfaty S; Chang TT; Palmer LM; Jobling MG; Holmes RK; Hol WG
Structure; 1995 Jun; 3(6):561-70. PubMed ID: 8590017
[TBL] [Abstract][Full Text] [Related]
49. Multi-scale molecular dynamics study of cholera pentamer binding to a GM1-phospholipid membrane.
Sridhar A; Kumar A; Dasmahapatra AK
J Mol Graph Model; 2016 Jul; 68():236-251. PubMed ID: 27474868
[TBL] [Abstract][Full Text] [Related]
50. Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells.
Wands AM; Cervin J; Huang H; Zhang Y; Youn G; Brautigam CA; Matson Dzebo M; Björklund P; Wallenius V; Bright DK; Bennett CS; Wittung-Stafshede P; Sampson NS; Yrlid U; Kohler JJ
ACS Infect Dis; 2018 May; 4(5):758-770. PubMed ID: 29411974
[TBL] [Abstract][Full Text] [Related]
51. On the role of the carboxyl group of sialic acid in binding of cholera toxin to the receptor glycosphingolipid, GM1.
Lanne B; Schierbeck B; Karlsson KA
J Biochem; 1994 Dec; 116(6):1269-74. PubMed ID: 7706216
[TBL] [Abstract][Full Text] [Related]
52. The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition.
Margheri G; D'Agostino R; Trigari S; Sottini S; Del Rosso M
Lipids; 2014 Feb; 49(2):203-6. PubMed ID: 24122042
[TBL] [Abstract][Full Text] [Related]
53. Solution dynamics of the oligosaccharide moiety of ganglioside GM1: comparison of solution conformations with the bound state conformation in association with cholera toxin B-pentamer.
Richardson JM; Milton MJ; Homans SW
J Mol Recognit; 1995; 8(6):358-62. PubMed ID: 9052976
[TBL] [Abstract][Full Text] [Related]
54. Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation.
Kaittanis C; Banerjee T; Santra S; Santiesteban OJ; Teter K; Perez JM
Bioconjug Chem; 2011 Feb; 22(2):307-14. PubMed ID: 21226491
[TBL] [Abstract][Full Text] [Related]
55. Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site.
Heim JB; Hodnik V; Heggelund JE; Anderluh G; Krengel U
Sci Rep; 2019 Aug; 9(1):12243. PubMed ID: 31439922
[TBL] [Abstract][Full Text] [Related]
56. Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay.
O'Hanlon GM; Hirst TR; Willison HJ
Neurosci Res; 2003 Dec; 47(4):383-90. PubMed ID: 14630342
[TBL] [Abstract][Full Text] [Related]
57. Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes.
Nedelkoska L; Benjamins JA
J Neurosci Res; 1998 Sep; 53(5):605-12. PubMed ID: 9726431
[TBL] [Abstract][Full Text] [Related]
58. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
Lauer S; Goldstein B; Nolan RL; Nolan JP
Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
[TBL] [Abstract][Full Text] [Related]
59. Structural studies of receptor binding by cholera toxin mutants.
Merritt EA; Sarfaty S; Jobling MG; Chang T; Holmes RK; Hirst TR; Hol WG
Protein Sci; 1997 Jul; 6(7):1516-28. PubMed ID: 9232653
[TBL] [Abstract][Full Text] [Related]
60. Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin.
Kellie S; Patel B; Pierce EJ; Critchley DR
J Cell Biol; 1983 Aug; 97(2):447-54. PubMed ID: 6684122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
